Caprock Group LLC Buys Shares of 14,095 HCA Healthcare, Inc. $HCA

Caprock Group LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, HoldingsChannel reports. The fund acquired 14,095 shares of the company’s stock, valued at approximately $5,694,000.

A number of other institutional investors and hedge funds have also made changes to their positions in HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter worth $1,021,000. NewEdge Advisors LLC boosted its holdings in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares in the last quarter. Concurrent Investment Advisors LLC grew its holdings in HCA Healthcare by 4.3% in the second quarter. Concurrent Investment Advisors LLC now owns 2,235 shares of the company’s stock worth $856,000 after purchasing an additional 93 shares during the last quarter. Finally, CWM LLC lifted its holdings in shares of HCA Healthcare by 5.4% during the 2nd quarter. CWM LLC now owns 13,062 shares of the company’s stock valued at $5,004,000 after purchasing an additional 667 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $530.95 on Thursday. The company has a 50 day simple moving average of $480.78 and a 200-day simple moving average of $446.23. The company has a market capitalization of $121.16 billion, a P/E ratio of 18.71, a P/E/G ratio of 1.54 and a beta of 1.36. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $534.59.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. During the same quarter in the prior year, the company posted $6.22 EPS. The company’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 10.15%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Argus raised their price target on HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. KeyCorp set a $503.00 price target on shares of HCA Healthcare in a report on Wednesday, January 28th. Wells Fargo & Company lifted their price target on HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a report on Monday, December 15th. Finally, Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $523.27.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised multiple near‑ and long‑term EPS forecasts for HCA (Q2–Q4 2026, several quarters in 2027, FY2027 and FY2028), boosting modeled future profitability even though Zacks retains a “Hold” rating — this analyst upgrade is a primary driver of the stock move.
• Positive Sentiment: HCA’s outpatient expansion continues to reshape its care network, increasing lower‑cost, higher‑margin ambulatory volumes that can lift revenue growth and operating margins over time. HCA’s outpatient boom reshapes its care network
• Positive Sentiment: StoneSprings Hospital Center plans to convert a deli into a freestanding ER in Chantilly — a localized capacity expansion to capture ED volume and downstream admissions/surgeries, signaling continued investment in site-of-care growth. HCA’s StoneSprings Hospital Center looks to turn Chantilly deli into freestanding ER
• Neutral Sentiment: HCA ASC real estate was sold — this monetizes noncore assets and can free cash (positive) but may imply sale‑leaseback obligations (costs) depending on terms; impact depends on deal structure and use of proceeds. HCA ASC real estate sold
• Neutral Sentiment: An HCA veteran has taken a COO role at Memorial Health (Georgia/Florida reports) — routine executive movement that highlights HCA’s management bench but likely has limited direct impact on HCA’s near‑term results. Former HCA Florida executive joins Memorial Health as COO HCA veteran named COO of Memorial Health in Georgia
• Neutral Sentiment: Other local developments and community activity (interfacility transport partnerships, Habitat build, internal nursing leadership moves) are operational/CSR items that support reputation and network functioning but are unlikely to move earnings materially in the near term. AmeriPro Health expands Fla. operations with new interfacility transport partnership HCA Healthcare leaders join Habitat build in Dorchester County HCA Missouri hospital taps chief nurse

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares of the company’s stock, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.